SCHEMBL5316982

SCHEMBL5316982

CCOC(=O)N1CCc2c([nH]c3ccc(Cl)cc23)C1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.65
SMN1; SMN2 Q16637 3/20 0.65
PABPC1 P11940 1/20 0.65
ATM Q13315 1/20 0.65
BAZ2B Q9UIF8 2/20 0.60
TRPV1 Q8NER1 9/20 0.52
KMT2A Q03164 4/20 0.51
MEN1 O00255 3/20 0.51
MAPT P10636 3/20 0.51
NPSR1 Q6W5P4 3/20 0.50
HSD17B10 Q99714 3/20 0.50
HPGD P15428 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
TSHR P16473 1/20 0.50
CYP2C19 P33261 1/20 0.50
FAAH O00519 1/20 0.50
MAPK1 P28482 3/20 0.49
KDM4E B2RXH2 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12868340 0.91 LMNA (0.79) LMNASMN1; SMN2PABPC1ATMBAZ2B
SCHEMBL11756284 0.90 LMNA (0.63) LMNASMN1; SMN2PABPC1ATMBAZ2B
SCHEMBL13049444 0.86 SMN1; SMN2 (0.65) LMNASMN1; SMN2PABPC1ATMBAZ2B
SCHEMBL3722389 0.85 BAZ2B (0.58) LMNASMN1; SMN2PABPC1ATMBAZ2B
SCHEMBL1867588 0.84 BAZ2B (0.81) LMNABAZ2BTRPV1MAPTGPX4
SCHEMBL12978505 0.84 TRPV1 (0.66) BAZ2BTRPV1KMT2AMEN1MAPT
SCHEMBL5375005 0.83 BAZ2B (0.64) BAZ2BTRPV1KMT2AMEN1MAPT
SCHEMBL21731891 0.80 TRPV1 (0.64) BAZ2BTRPV1
SCHEMBL21731973 0.80 HDAC6 (0.59) BAZ2BTRPV1KMT2AMEN1MAPT
SCHEMBL5264982 0.79 BAZ2B (0.59) BAZ2BTRPV1KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1824821-A2 CARBAZOLE, CARBOLINE AND INDOLE DERIVATIVES USEFUL IN THE INHIBITION OF VEGF PRODUCTION PTC Therapeutics, Inc. (US) 2007-08-29 EP disclosed
WO-2006058088-A2 CARBAZOLE, CARBOLINE AND INDOLE DERIVATIVES USEFUL IN THE INHIBITION OF VEGF PRODUCTION PTC THERAPEUTICS, INC. (US) 2006-06-01 WO disclosed